Sandoz Group AG (Sandoz Group AG) EV-to-EBITDA : (As of May. 13, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sandoz Group AG's enterprise value is $18,891 Mil. Sandoz Group AG does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Sandoz Group AG's EV-to-EBITDA at this moment.

The historical rank and industry rank for Sandoz Group AG's EV-to-EBITDA or its related term are showing as below:

SDZNY' s EV-to-EBITDA Range Over the Past 10 Years
Min: -603572.4 Med: 0 Max: 23.09
Current: 23.09

During the past 2 years, the highest EV-to-EBITDA of Sandoz Group AG was 23.09. The lowest was -603572.40. And the median was 0.00.

SDZNY's EV-to-EBITDA is ranked worse than
71.89% of 708 companies
in the Drug Manufacturers industry
Industry Median: 14.76 vs SDZNY: 23.09

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-13), Sandoz Group AG's stock price is $35.98. Sandoz Group AG does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Sandoz Group AG's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Sandoz Group AG EV-to-EBITDA Historical Data

The historical data trend for Sandoz Group AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG EV-to-EBITDA Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

EV-to-EBITDA

20.09

Sandoz Group AG Quarterly Data
	Dec22	Dec23
EV-to-EBITDA	-	-

Competitive Comparison of Sandoz Group AG's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sandoz Group AG's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's EV-to-EBITDA falls into.

Sandoz Group AG EV-to-EBITDA Calculation

Sandoz Group AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	18890.662	/
	=

Sandoz Group AG (OTCPK:SDZNY) EV-to-EBITDA Explanation

Sandoz Group AG's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	35.98	/
	=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Sandoz Group AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG (Sandoz Group AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZz:UK D8Y0:Germany SDZ:Switzerland

Address

Forum 1, Novartis Campus, Basel, CHE, CH-4056

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024